Thanks for the answers Fouremm and everyone who chimed in.....BDZ you are awesome.
Again, I wasn't trying to be combative here, just trying to get my head around things and I know that can be exasperating for others.
I will toss in another question...something DM mentioned during the presentation, EGFR. Would the company, the steering committee, the DSMB....would they have access to general data on EGFR or any other secondary endpoints?